MacroGenics Inc (MGNX) - Financial and Strategic SWOT Analysis Review

  • ID: 4318238
  • SWOT Analysis
  • 50 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Genentech Inc
  • Genmab A/S
  • Puma Biotechnology Inc
  • Xencor Inc
  • MORE
MacroGenics Inc (MGNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

MacroGenics Inc (MacroGenics) is a clinical-stage biopharmaceutical company which focuses on the discovery, development and delivery of novel antibody-based therapeutics for the treatment of cancer, infectious diseases and autoimmune disorders. Its pipeline includes product candidates for the treatment of solid tumors, breast and gastroesophageal cancers type 1 diabetes, HIV, leukemia; and DART product candidates for the treatment of acute myeloid leukemia and myelodysplastic syndrome; colorectal cancer; and b-cell malignancies. The company’s product candidates are based on three core proprietary technology platforms, namely, Cancer Stem Cell Platform, Dual-Affinity Re-Targeting (or DART) and TRIDENT Platform and Fc Optimization Platform. It also works in collaboration with major pharmaceutical and biotechnology companies to leverage its technology platforms and protein engineering capabilities to develop product candidates. MacroGenics is headquartered in Rockville, Maryland, the US.

MacroGenics Inc Key Recent Developments

May 07, 2018: MacroGenics Provides Update on Corporate Progress and 1st Quarter 2018 Financial Results
Feb 27, 2018: MacroGenics Reports 2017 Financial Results
Nov 15, 2017: MacroGenics Names Dr. Jay Siegel to its Board of Directors
Nov 08, 2017: MacroGenics Provides Update on Corporate Progress and Third Quarter 2017 Financial Results
Aug 02, 2017: MacroGenics Provides Update on Corporate Progress and Second Quarter 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Genentech Inc
  • Genmab A/S
  • Puma Biotechnology Inc
  • Xencor Inc
  • MORE
Section 1 - About the Company
  • MacroGenics Inc - Key Facts
  • MacroGenics Inc - Key Employees
  • MacroGenics Inc - Key Employee Biographies
  • MacroGenics Inc - Major Products and Services
  • MacroGenics Inc - History
  • MacroGenics Inc - Company Statement
  • MacroGenics Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • MacroGenics Inc - Business Description
  • MacroGenics Inc - Corporate Strategy
  • MacroGenics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • MacroGenics Inc - Strengths
  • MacroGenics Inc - Weaknesses
  • MacroGenics Inc - Opportunities
  • MacroGenics Inc - Threats
  • MacroGenics Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • MacroGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • MacroGenics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • MacroGenics Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 07, 2018: MacroGenics Provides Update on Corporate Progress and 1st Quarter 2018 Financial Results
  • Nov 15, 2017: MacroGenics Names Dr. Jay Siegel to its Board of Directors
  • Nov 08, 2017: MacroGenics Provides Update on Corporate Progress and Third Quarter 2017 Financial Results
  • Aug 02, 2017: MacroGenics Provides Update on Corporate Progress and Second Quarter 2017 Financial Results
  • May 03, 2017: MacroGenics Provides Update on Corporate Progress and 1st Quarter 2017 Financial Results
  • Mar 31, 2017: Eight Posters Based on MacroGenics-developed Molecules Featured at AACR Annual Meeting 2017
  • Feb 28, 2017: MacroGenics Provides Update on Corporate Progress and 2016 Financial Results
  • Jan 25, 2017: MacroGenics Announces Appointments to Board of Directors
  • Jan 25, 2017: MacroGenics Announces Appointments to Board of Directors
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • MacroGenics Inc, Key Facts
  • MacroGenics Inc, Key Employees
  • MacroGenics Inc, Key Employee Biographies
  • MacroGenics Inc, Major Products and Services
  • MacroGenics Inc, History
  • MacroGenics Inc, Other Locations
  • MacroGenics Inc, Key Competitors
  • MacroGenics Inc, Ratios based on current share price
  • MacroGenics Inc, Annual Ratios
  • MacroGenics Inc, Annual Ratios
  • MacroGenics Inc, Annual Ratios
  • MacroGenics Inc, Interim Ratios
  • MacroGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • MacroGenics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • MacroGenics Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • MacroGenics Inc, Performance Chart (2013 - 2017)
  • MacroGenics Inc, Ratio Charts
  • MacroGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • MacroGenics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Xencor Inc
  • Puma Biotechnology Inc
  • Genmab A/S
  • Genentech Inc
  • Cascadian Therapeutics Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll